ADAM9 and familial pancreatic carcinoma: The findings demonstrated that miR-126-3p shuttled by BMSC-derived exosome, by downregulating ADAM9, suppressed proliferation, invasion, and metastasis and promoted apoptosis in pancreatic cancer cells, thus acting as a potential biomarker for the treatment of pancreatic cancer.